Silvio Inzucchi

Financial relationships

  • Attribution:
    Self
    Type of financial relationship:
    Financial Support
    Ineligible company:
    Novo Nordisk
    Topic:
    diabetes
    Date added:
    09/13/2026
    Date updated:
    09/13/2026
  • Attribution:
    Self
    Type of financial relationship:
    Financial Support
    Ineligible company:
    Astra Zeneca
    Topic:
    diabetes
    Date added:
    09/13/2026
    Date updated:
    09/13/2026
  • Attribution:
    Self
    Type of financial relationship:
    Financial Support
    Ineligible company:
    Boehringer Ingelheim
    Topic:
    diabetes
    Date added:
    09/13/2026
    Date updated:
    09/13/2026
  • Attribution:
    Self
    Type of financial relationship:
    Financial Support
    Ineligible company:
    Corcept
    Topic:
    diabetes
    Date added:
    09/13/2026
    Date updated:
    09/13/2026
  • Attribution:
    Self
    Type of financial relationship:
    Financial Support
    Ineligible company:
    Madrigal
    Topic:
    MASLD
    Date added:
    09/13/2026
    Date updated:
    09/13/2026
  • Attribution:
    Self
    Type of financial relationship:
    Financial Support
    Ineligible company:
    AnaCardio
    Topic:
    Heart failure
    Date added:
    09/13/2026
    Date updated:
    09/13/2026
Return to SGLT2 inhibitors: How Did Mediocre Glucose Lowering Agents Become Cornerstones of Cardiovascular Therapy?